A call to action for the treatment of acute promyelocytic leukemia in the modern era: It is no longer just about the ATRA and arsenic-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A call to action for the treatment of acute promyelocytic leukemia in the modern era: It is no longer just about the ATRA and arsenic

Published:2021-04-23 Issue:16 Volume:127 Page:2867-2869
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pemmaraju Naveen¹^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33594

Reference24 articles.

1. Impact of insurance status on the survival of younger patients diagnosed with acute promyelocytic leukemia in the United States;Jamy OH;Cancer,2021

2. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

3. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

4. Health care in the United States—basic human right or entitlement?

5. How I treat acute myeloid leukemia in the era of new drugs

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP